SELLAS Life Sciences Group's total assets for Q4 2024 were $19.43M, a decrease of -26.69% from the previous quarter. SLS total liabilities were $9.97M for the fiscal quarter, a -6.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.